Interleukin-1 receptor-like 2 — Drug Target

All drugs that target Interleukin-1 receptor-like 2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Interleukin-36 Receptor Antagonist [EPC]

Marketed (2)

• Spevigo · Boehringer Ingelheim Pharmaceuticals Inc · Interleukin-36 Receptor Antagonist [EPC] · Immunology
  Spevigo works by blocking the interleukin-36 receptor, which plays a key role in the development of psoriasis symptoms.
• SPEVIGO · BOEHRINGER INGELHEIM PHARMACEUTICALS INC · Interleukin-36 Receptor Antagonist [EPC] · Immunology